Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray has become the fifth largest craft brewer in the U.S. The company hopes that federal cannabis legalization in the U.S. will allow it to eventually combine its two segments.

Why Tilray Shares Jumped While the Market Dropped Today

Tilray Brands has been steadily building a top-shelf cannabis and consumer packaged-goods company. Monday, the company announced a deal with Anheuser-Busch to acquire eight beer and beverage brands.

Is Tilray Brands Stock a Screaming Buy in August?

Anheuser-Busch InBev

Tilray Brands (NASDAQ: TLRY ) is continuing its expansion into alcohol by buying $85 million worth of beer brands from Anheuser-Busch InBev (NYSE: BUD ), makers of Bud Light. The deal is part of a Tilray diversification effort that began with its purchase of rival Aphria in 2021.

TLRY Stock Alert: Can New Anheuser-Busch Brands Save Tilray?

By buying 8 craft beer and beverage brands from ABInBev Canadian cannabis company has become a major force in the United States alcohol market and has set its self up for future growth.

Tilray Brands Deal With Anheuser-Busch InBev Sets Them Firmly On The National Stage

EVgo

Kinross Gold

Weed, gold, and electric vehicle chargers. This unlikely trio stands among the best investments that can possibly double your money in the next year.

3 Sizzling Stocks Under $5 With Double-in-a-Year Potential

The Bud Light owner is selling eight beer and beverage brands for an undisclosed amount.

Anheuser-Busch Selling Shock Top, Blue Point to Cannabis Company Tilray

Canadian cannabis producer Tilray Brands Inc. TLRY, -3.48% on Monday said it had agreed to buy eight beer and drink brands from Anheuser-Busch InBev BUD, -0.09% — including Shock Top, Redhook Brewery and Widmer Brothers Brewing. The other five brands are Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Square Mile Cider Co. and HiBall Energy.

Canadian pot company Tilray is buying 8 beer and beverage brands from AB InBev

Acquisition is Expected to Position Tilray as the 5 th 1 Largest Craft Beer Brewer in the U.S. with 5% 2 Craft Beer Market Share

Tilray Brands Announces Agreement to Acquire Eight Beer & Beverage Brands From Anheuser-Busch, Fueling Tilray's Future in the U.S. Craft Beer Industry

Bitfarms Ltd

Hydrofarm Holdings Group

Nordic American Tankers

Polestar Automotive Holding UK PLC

Standard Lithium Ltd

There is no shortage of action in the penny stock space. Even in relatively subdued markets, selected penny stocks can deliver multibagger returns.

7 Cheap Penny Stocks That Smart Investors Will Snap Up Now

Tilray generated an impressive 20% growth in sales this past quarter. The company's net loss was also a fraction of what it was a year ago.

Is Tilray Brands Stock Out of the Woods After an Improved Q4?

Despite challenges in Canada, Tilray's revenue increased in the recent quarter. Its global presence may help it thrive as the cannabis market evolves worldwide.

1 Green Flag and 1 Red Flag for Tilray Stock

Cronos Group

Curaleaf Holdings, Inc.

For long, investors in the cannabis industry have pinned hopes on federal-level legalization. Without a doubt, that's a big catalyst for growth for the cannabis industry.

3 Cannabis Stocks That Have 10-Bagger Potential

Canopy Growth

How long are marijuana stock investors going to hold on? What this means is much of the cannabis sector has an unpredictable way of performing. For example, there is no way to tell or be truly sure when cannabis stock will rise. At one point in time essentially any positive casualty would help bring trading up. For some time that has not been the case so what keeps investors so interested? Well, not all are as confident as others but with how young the cannabis industry still is there is much to stay optimistic about.

3 Marijuana Stocks To Watch First Week Of August

Tilray is aiming to scale-up its alcohol sales. It's also generating more cash than before.

2 New Reasons to Buy Tilray Brands Stock in August

The fascinating world of cannabis! In recent years, this exciting sector has attracted the interest of investors and consumers alike.

3 Cannabis Stocks to Buy Before the Breakout

Tilray's Q4 earnings for its 2023 fiscal year succeeded in wowing the market. Its marijuana market share in Canada is resurging after a long decline.

Up 25% in 1 Day, Is Tilray Brands Stock a Buy Now?

Imac Holdings Inc

Eastman Kodak

Penny stocks are generally defined as securities that trade for less than $5 a share. These stocks can be volatile and unpredictable, leading many investors to avoid them.

If You Can Only Buy One Penny Stock, It Better Be One of These 3 Names

LEAMINGTON, Ontario, July 27, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company and Great North Distributors, Inc. (Great North), Canada's leading national sales broker for legalized adult-use cannabis — today announced a renewed national brokerage agreement. Under the agreement, Great North will continue to be the exclusive representative for Tilray's full portfolio of recreational cannabis products across the Canadian marketplace, with the exception of Quebec.

Tilray Renews Distribution Agreement With Great North Distributors for Cannabis Sales Across Canada With Newly Expanded Brand Portfolio

Tilray delivered a pleasant surprise to investors: Sales were up 20% year over year in its fiscal Q4. The cannabis company also reduced its losses, and produced positive operating cash flow for both the quarter and the year.

Why Tilray Brands Stock Soared 17% Today

Tilray Brands, Inc. (NASDAQ:TLRY ) Q4 2023 Earnings Call Transcript July 26, 2023 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - Chairman and Chief Executive Officer Carl Merton - Chief Financial Officer Blair MacNeil - President, Canada Denise Faltischek - Chief Strategy Officer, Head of International Conference Call Participants Vivien Azer - TD Cowen Andrew Carter - Stifel Owen Bennett - Jefferies Aaron Grey - Alliance Global Partners Nadine Sarwat - Bernstein Tamy Chen - BMO Capital Markets Yewon Kang - Canaccord Genuity John Zamparo - CIBC Michael Lavery - Piper Sandler Frederico Gomes - ATB Capital Markets Operator Hello, and thank you for joining today's conference call to discuss Tilray Brands, Inc.'s Financial Results for the Fiscal Year 2023 and Fourth Quarter Ended May 31, 2023. All lines have been placed on mute to prevent any background noise.

Tilray Brands, Inc. (TLRY) Q4 2023 Earnings Call Transcript

The headline numbers for Tilray Brands, Inc. (TLRY) give insight into how the company performed in the quarter ended May 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Tilray Brands, Inc. (TLRY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While a Canadian company, Tilray has been positioning itself to be a leader in the U.S. adult-use cannabis market.

Tilray stock surges after cannabis company improves bottom line

Tilray Brands, Inc. (TLRY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.34 per share a year ago.

Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q4

Tilray Brands Inc. TLRY, -0.59% stock was up 3% in premarket trades on Wednesday after the cannabis company reported a narrower fourth-quarter loss that missed Wall Street expectations, while its revenue beat analyst projections. Tilray said its net loss for the three months ended May 31 narrowed to $119.8 million, or 15 cents a share, from a loss of $457.8 million, or 99 cents a share, in the year-ago quarter.

Cannabis company Tilray posts narrower loss as revenue climbs 20%

Record Q4 Net Revenue of $184 Million, Representing 20% Growth Year over Year, $627 Million of Net Revenue for FY2023; On a Constant Currency Basis, FY2023 Net Revenue Grew 6% to $668 Million

News for Tilray Brands Stock (TLRY)